HPV vaccination in women aged 24-45 years

Lancet. 2009 Oct 10;374(9697):1239; author reply 1239-40. doi: 10.1016/S0140-6736(09)61782-7.
No abstract available

Publication types

  • Comment
  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Female
  • Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
  • Humans
  • Middle Aged
  • Papillomavirus Vaccines / immunology*
  • Public Health*
  • Randomized Controlled Trials as Topic*
  • Research Design*
  • Uterine Cervical Dysplasia / epidemiology
  • Uterine Cervical Dysplasia / prevention & control
  • Uterine Cervical Dysplasia / virology
  • Vaccination

Substances

  • Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
  • Papillomavirus Vaccines